Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

As part of this initiative, Invest UP — the state’s nodal investment promotion agency — is organising a series of global ...

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

Discover how businesses support global water goals, reducing risks and restoring ecosystems with the Freshwater Challenge by 2030.

Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...

GSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking ...

The vaccine, Mosquirix or RTS,S, was developed by GSK and the non-profit PATH, and was the first malaria vaccine to get ...

EMA accepts GSK’s MAA for linerixibat for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Tuesday, June 24, 2025, 09:00 Hrs [IST] GSK plc announced ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...